Patterson Nicole A, Smith Jessica L, Ozbun Michelle A
Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA.
J Virol. 2005 Jun;79(11):6838-47. doi: 10.1128/JVI.79.11.6838-6847.2005.
Oncogenic human papillomaviruses (HPVs) are difficult to study experimentally as they replicate at low levels in vivo. This has precluded the purification of high-risk HPV virions from in vivo lesions. Virus-like particles (VLPs) and pseudovirions from low- and high-risk HPV types can emulate various aspects of HPV virion attachment and infections. These studies suggest that HPV infection is mediated by alpha6-integrin and/or heparan-sulfonated receptors. However, whether VLPs and pseudovirions accurately reflect the infection process of HPV virions has not been verified. We generated infectious HPV31b virions from organotypic (raft) tissues and performed experimental infections in a variety of cells. Successful infection following viral attachment, internalization, and nuclear transport was assayed by detecting newly synthesized, spliced HPV transcripts using reverse transcription (RT)-PCR or RT-quantitative PCR. Most human epithelial cells were infected with HPV31b at a multiplicity of infection as low as 1 to 10 viral genome equivalents per cell. HPV31b infection was detected in other cell lines, including COS-7 monkey kidney cells, but higher viral multiplicities of infection were required. Heparin preparations of various molecular weights or heparinase I treatment of cells prevented HPV31b infection of COS-7 cells and C-33A human cervical cancer cells in reproducible and dose-dependent manners. However, these reagents were unable to block infection of human keratinocytes, including HaCaT and N/TERT-1 cells and low-passage human foreskin keratinocytes. These data suggest that HPV31b infection of human keratinocytes, the natural host cell for HPV infections in vivo, does not require a heparan-sulfonated receptor, whereas heparan sulfate is important for infection of some other cells.
致癌性人乳头瘤病毒(HPV)在体内复制水平较低,因此很难通过实验进行研究。这使得无法从体内病变中纯化出高危型HPV病毒粒子。来自低危型和高危型HPV的病毒样颗粒(VLP)和假病毒可以模拟HPV病毒粒子附着和感染的各个方面。这些研究表明,HPV感染是由α6整合素和/或硫酸乙酰肝素受体介导的。然而,VLP和假病毒是否准确反映HPV病毒粒子的感染过程尚未得到验证。我们从器官型(筏)组织中产生了具有感染性的HPV31b病毒粒子,并在多种细胞中进行了实验性感染。通过使用逆转录(RT)-PCR或RT定量PCR检测新合成的、剪接的HPV转录本来测定病毒附着、内化和核转运后的成功感染情况。大多数人上皮细胞在感染复数低至每细胞1至10个病毒基因组当量时被HPV31b感染。在其他细胞系中也检测到了HPV31b感染,包括COS-7猴肾细胞,但需要更高的病毒感染复数。不同分子量的肝素制剂或对细胞进行肝素酶I处理,以可重复的、剂量依赖的方式阻止了COS-7细胞和C-33A人宫颈癌细胞被HPV31b感染。然而,这些试剂无法阻断人角质形成细胞的感染,包括HaCaT和N/TERT-1细胞以及低代人包皮角质形成细胞。这些数据表明,HPV31b对人角质形成细胞(体内HPV感染的天然宿主细胞)的感染不需要硫酸乙酰肝素受体,而硫酸乙酰肝素对其他一些细胞的感染很重要。